Investigations of Interactions Between Altretamine and Model Membranes: Spectroscopic and Calorimetric Analysis

Author:

Bilge D.1,Civelek N.1,Özçelik Çetinel Z.1

Affiliation:

1. Faculty of Science, Department of Physics, Ege University, Bornova-Izmir 35100, Turkey

Abstract

Altretamine (ALT) is a Food and Drug Administration (FDA) approved antineoplastic drug particularly used for ovarian cancer. This study examined, at a molecular level, the interactions of the drug with model membranes composed of phospholipids with different acyl chain lengths and head group charges at varied ALT concentrations based on temperature. For this purpose, spectroscopic studies of the liposomes in multilamellar vesicles form were conducted by Fourier transform-infrared spectroscopy (FTIR) and their calorimetric studies were carried out by differential scanning calorimetry (DSC) techniques. The results of the study showed that ALT clearly interacted with lipids and that these interactions were more significant in multilamellar vesicles made up of short chain phospholipids. Moreover, the results suggested that ALT settled into the tail group region, in particular the region that formed the hydrophobic part of lipids, and this effects the whole section of the membranes including glycerol backbones and head groups. This study is expected to contribute, on molecular level, to the studies on the knowledge of the mechanism in cancer, which is still very much a dangerous disease, and its related treatment.

Funder

Ege University Research Fund

Publisher

World Scientific Pub Co Pte Lt

Subject

Molecular Biology,Structural Biology,Biophysics

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3